Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 SEK | -0.22% |
|
+2.04% | -59.09% |
Jul. 02 | NeoDynamics Secures Approval to Delist from Nasdaq First North | MT |
Jun. 18 | Norse Atlantic to Operate Boeing 787 Routes for Neos in Winter | MT |
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.8 for the current period. Therefore, the company is undervalued.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- One of the major weak points of the company is its financial situation.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-59.09% | 2.77M | - | ||
-33.70% | 14.31B | A | ||
-57.92% | 2.1B | C+ | ||
+22.96% | 1.95B | - | ||
-23.94% | 1.28B | - | ||
+19.67% | 1.21B | B+ | ||
+1.10% | 779M | - | ||
-37.32% | 748M | - | ||
-37.03% | 720M | - | C- | |
-29.95% | 596M | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NEOD Stock
- Ratings NEOS AB